TD Asset Management’s GeneDx Holdings WGS Stock Holding History

TD Asset Management’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-37,016	Closed	-$4.81M	–	1305
2025 Q4	$4.81M	Buy	37,016 +3,584	+11%	+$492K	﹤0.01%	806
2025 Q3	$3.6M	Sell	33,432 -1,826	-5%	-$199K	﹤0.01%	841
2025 Q2	$3.25M	Buy	35,258 +18,310	+108%	+$1.44M	﹤0.01%	834
2025 Q1	$1.5M	Buy	16,948 +9,114	+116%	+$791K	﹤0.01%	1022
2024 Q4	$602K	Buy	7,834 +1,400	+22%	+$97.8K	﹤0.01%	1169
2024 Q3	$275K	Buy	+6,434	New	+$217K	﹤0.01%	1347
2023 Q1	–	Sell	-3,216	Closed	-$28K	–	1467
2022 Q4	$28K	Hold	3,216	–	–	﹤0.01%	1424
2022 Q3	$96K	Hold	3,216	–	–	﹤0.01%	1428
2022 Q2	$134K	Hold	3,216	–	–	﹤0.01%	1404
2022 Q1	$326K	Hold	3,216	–	–	﹤0.01%	1385
2021 Q4	$473K	Hold	3,216	–	–	﹤0.01%	1393
2021 Q3	$806K	Buy	+3,216	New	+$1.1M	﹤0.01%	1302

Other funds holding WGS

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

ZDA

Zweig-DiMenna Associates New York $1.1B AUM 171.86% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TD Asset Management's WGS Position: Q1 2026 in Review

TD Asset Management sold out of GeneDx Holdings (WGS) in Q1 2026, closing a stake of 37,016 shares — an estimated $4.81M sold.

TD Asset Management first reported a position in WGS in Q3 2021 and held it in 12 quarters. The position peaked at $4.81M in Q4 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

TD Asset Management reported no remaining GeneDx Holdings position as of Q1 2026 after selling out during the quarter.
TD Asset Management sold 37,016 GeneDx Holdings shares in Q1 2026, an estimated $4.81M.
TD Asset Management first reported a position in GeneDx Holdings in Q3 2021 and held it in 12 quarters.
TD Asset Management's GeneDx Holdings position peaked at $4.81M in Q4 2025.
240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on TD Asset Management's 13F filing for Q1 2026, filed 11 May 2026.